Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2026-01-07 @ 3:10 AM
Study NCT ID:
NCT05720533
Status:
UNKNOWN
Last Update Posted:
2023-02-09
First Post:
2023-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization: